Who owns ONCOCYTE CORPORATION COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Oncocyte Corporation with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oncocyte Corporation stock

Who bought or sold ONCOCYTE CORPORATION COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pura Vida Investments 524k $1.5M -20% Mar 2024
 View chart
Vanguard Group 248k $726k 0% Mar 2024
 View chart
Morgan Stanley 123k $361k -12% Mar 2024
 View chart
Geode Capital Management 62k $183k 2% Mar 2024
 View chart
BlackRock 60k $176k 0% Mar 2024
 View chart
Tower Research Capital 1.9k $5.5k -26% Mar 2024
 View chart
UBS Group 864.00 $2.5k -37% Mar 2024
 View chart
Pnc Financial Services 500.00 $1.5k 0% Mar 2024
 View chart
Bank of America Corporation 210.00 $615.006000 -3% Mar 2024
 View chart
Jpmorgan Chase & Co 154.00 $451.004400 0% Mar 2024
 View chart
Nbc Securities 150.00 $1.0k 100% Mar 2024
 View chart
Advisor Group Holdings 97.00 $282.745300 0% Mar 2024
 View chart
Royal Bank of Canada 80.00 $0 -91% Mar 2024
 View chart
Wells Fargo & Company 61.00 $178.864200 2% Mar 2024
 View chart
Riggs Asset Managment 50.00 $147.000000 0% Mar 2024
 View chart
Piscataqua Savings Bank 25.00 $73.000000 0% Mar 2024
 View chart
Brian McDonald 23.00 $66.999000 -38% Mar 2024
 View chart
FMR 13.00 $38.000300 100% Mar 2024
 View chart
Coppell Advisory Solutions 10.00 $25.000000 100% Dec 2023
 View chart
Albion Financial Group 7.00 $21.000000 0% Mar 2024
 View chart
Qube Research & Technologies 1.00 $3.000000 0% Mar 2024
 View chart
Rhumbline Advisers 0 $0 -100% Mar 2024
 View chart

Who sold out of Oncocyte Corporation?

Fund or Company Name Date Sold Shares Held Valued At
Lindbrook Capital Dec 2023 4.00 $10.000000